Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12618001996257
Ethics application status
Approved
Date submitted
29/11/2018
Date registered
12/12/2018
Date last updated
20/01/2020
Date data sharing statement initially provided
12/12/2018
Date results information initially provided
20/01/2020
Type of registration
Retrospectively registered
Titles & IDs
Public title
A study to assess the effects of Rapid Recovery on the adverse effects of alcohol consumption
Query!
Scientific title
A double blind randomized placebo controlled crossover study to assess the effects of Rapid Recovery on the adverse after effects of alcohol consumption possibly due to acetaldehyde
Query!
Secondary ID [1]
296744
0
Nill
Query!
Universal Trial Number (UTN)
UTN 1111-1224-7234
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
hangover
310621
0
Query!
Condition category
Condition code
Metabolic and Endocrine
309338
309338
0
0
Query!
Normal metabolism and endocrine development and function
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
750mg once daily
Administration over two days 2 capsules first dose at the end of the consumption of alcohol 2 capsules the second dose the following morning
First dose given at site by site staff.
Second dose recorded by patient time and date and returned to staff the following day
There is a seven day washout period
Each capsule contains l-cysteine hydrochloride 80mg, ascorbic acid 400mg, thiamine hydrochloride 80mg, pyridixine hydrochloride 20mg
Alcohol was consumed 1.3 mg per kilogram for each participant all drinks had the time and amount recorded so that they could be repeated on the following study day
Query!
Intervention code [1]
313060
0
Prevention
Query!
Comparator / control treatment
Corn flour capsules
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
308292
0
Validated questionnaire for Hangover Symptom Severity.
As described by Hogewoning et al overall hangover severity was measured using a single one-item rating and severity of 23 hangover symptoms that was rated on an 11-point Likert scale ranging from 0 to 10. The 23 items were derived from the Alcohol Hangover Severity Scale, the Hangover Symptoms Scale, and the Acute Hangover Scale.
Query!
Assessment method [1]
308292
0
Query!
Timepoint [1]
308292
0
all scientific data was collected the day following the alcohol consumption.
Query!
Secondary outcome [1]
354552
0
simulated driving ability. This will be assessed using Schuhfried driving/cognitive testing computer. This is a validated assessment of driving ability.
Query!
Assessment method [1]
354552
0
Query!
Timepoint [1]
354552
0
one day after the first dose
Query!
Secondary outcome [2]
354553
0
High sensitivity C reactive protein and Gamma GT this is a composite secondary outcome looking at these two inflammatory markers. by serum analysis.
Query!
Assessment method [2]
354553
0
Query!
Timepoint [2]
354553
0
Baseline, visit 1 and Visit 2
Query!
Eligibility
Key inclusion criteria
Normal males and females who have suffered a hangover in the previous year
Query!
Minimum age
25
Years
Query!
Query!
Maximum age
50
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Have either a drug or alcohol problem or any medical condition that is considered by the Medical practitioner as unsuitable
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Randomization by an independent pharmacy into sealed numbered envelopes
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Random computerized number generator
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Crossover
Query!
Other design features
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Paired t-tests
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
10/11/2018
Query!
Date of last participant enrolment
Anticipated
22/12/2018
Query!
Actual
22/12/2018
Query!
Date of last data collection
Anticipated
31/12/2018
Query!
Actual
1/06/2019
Query!
Sample size
Target
25
Query!
Accrual to date
Query!
Final
25
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment postcode(s) [1]
24973
0
3122 - Hawthorn
Query!
Recruitment postcode(s) [2]
24974
0
3122 - Hawthorn North
Query!
Recruitment postcode(s) [3]
24975
0
3122 - Hawthorn West
Query!
Funding & Sponsors
Funding source category [1]
301324
0
Commercial sector/Industry
Query!
Name [1]
301324
0
Phoenix Pharmaceuticals Pty Ltd
Query!
Address [1]
301324
0
PO Box 820 Sanctuary Cove
Sanctuary Cove 4212
Queensland
Query!
Country [1]
301324
0
Australia
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
Phoenix Pharmaceuticals Pty Ltd
Query!
Address
PO Box 820 Sanctuary Cove
Sanctuary Cove 4212
Queensland
Query!
Country
Australia
Query!
Secondary sponsor category [1]
300993
0
None
Query!
Name [1]
300993
0
Query!
Address [1]
300993
0
Query!
Country [1]
300993
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
302065
0
Swinburne University of Technology Human Ethics Committee
Query!
Ethics committee address [1]
302065
0
Swinburne University
John Street
Hawthorn 3221
Victoria
Query!
Ethics committee country [1]
302065
0
Australia
Query!
Date submitted for ethics approval [1]
302065
0
27/07/2018
Query!
Approval date [1]
302065
0
30/07/2018
Query!
Ethics approval number [1]
302065
0
SHR Project 2018/275
Query!
Summary
Brief summary
The aim of the study is to assess the efficacy of a natural treatment for the symptoms of the adverse after effects f alcohol. The product Rapid Recovery has been developed based on the scientifically supported rationales using several methods of reducing acetaldehyde ( a major metabolite of alcohol) toxicity which is believed to be a major mediator in the adverse after effects of alcohol consumption. Adverse effects of alcohol consumption will be measured the following day using visual analog scales of validated symptoms. In addition blood alcohol concentrations will be measured prior to commencing the study and at the end of the evening drinking and immediately prior to undertaking visual analog scales. Blood sampling will be performed on the first night of the trial and then on the morning after alcohol has been consumed. There have been reports that that there may be an inflammatory response due to acetaldehyde toxicity.
Query!
Trial website
none
Query!
Trial related presentations / publications
none
Query!
Public notes
none
Query!
Contacts
Principal investigator
Name
89006
0
Dr Sarah Benson
Query!
Address
89006
0
Swinburne University
John Street
Hawthorn 3221
Victoria
Query!
Country
89006
0
Australia
Query!
Phone
89006
0
+61 03 9214 8000
Query!
Fax
89006
0
Query!
Email
89006
0
[email protected]
Query!
Contact person for public queries
Name
89007
0
Dr Sarah Benson
Query!
Address
89007
0
Swinburne University
John Street
Hawthorn 3221
Victoria
Query!
Country
89007
0
Australia
Query!
Phone
89007
0
+61 03 9214 8000
Query!
Fax
89007
0
Query!
Email
89007
0
[email protected]
Query!
Contact person for scientific queries
Name
89008
0
Dr Sarah Benson
Query!
Address
89008
0
Swinburne University
John Street
Hawthorn 3221
Victoria
Query!
Country
89008
0
Australia
Query!
Phone
89008
0
+61 039241 8000
Query!
Fax
89008
0
Query!
Email
89008
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
This will be discussed with the PI
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Effects of rapid recovery on alcohol hangover severity: A double-blind, placebo-controlled, randomized, balanced crossover trial.
2020
https://dx.doi.org/10.3390/jcm9072175
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF